Number Т. 10, № 1-2 (37-38) 2020

Brentuхіmab vedotin in the treatment of Hodgkin’s lymphoma

Kriachok I.A., Titorenko I.B.

Summary. Brentuximab vedotin has been established as a highly effective drug that is included in the main treatment protocols of Hodgkin’s lymphoma. This article presents a list of studies that demonstrate the effectiveness of brentuximab vedotin both in monotherapy and in combination with different drugs for patients with relapsed/refractory Hodgkin’s lymphoma.
No Comments » Add your
Leave a comment